Reinhard Edmund Voll

Reinhard Edmund Voll's AcademicInfluence.com Rankings

Biology

#13114

World Rank

#16641

Historical Rank

Immunology

#895

World Rank

#918

Historical Rank

biology Degrees

Download Badge

Biology

Reinhard Edmund Voll's Degrees

PhD Immunology Stanford University
Doctorate Medicine Stanford University

Why Is Reinhard Edmund Voll Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Reinhard Edmund Voll's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Immunosuppressive effects of apoptotic cells (1997) (1866)
Phosphorylation of NF-kappa B p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300. (1998) (1282)
Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis (2010) (1194)
Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus. (1998) (880)
A rapid and simple method for the isolation of apoptotic DNA fragments. (1994) (677)
Impaired uptake of apoptotic cells into tingible body macrophages in germinal centers of patients with systemic lupus erythematosus. (2002) (563)
The proteasome inhibitor bortezomib depletes plasma cells and protects mice with lupus-like disease from nephritis (2008) (543)
Induction of inflammatory and immune responses by HMGB1–nucleosome complexes: implications for the pathogenesis of SLE (2008) (525)
Release of High Mobility Group Box 1 by Dendritic Cells Controls T Cell Activation via the Receptor for Advanced Glycation End Products1 (2005) (524)
Extensive immunoglobulin production sensitizes myeloma cells for proteasome inhibition. (2007) (388)
NF-kappa B activation by the pre-T cell receptor serves as a selective survival signal in T lymphocyte development. (2000) (300)
Clearance deficiency and systemic lupus erythematosus (SLE). (2007) (294)
The proteasome inhibitior bortezomib depletes plasma cells and ameliorates clinical manifestations of refractory systemic lupus erythematosus (2015) (281)
Genome-wide association meta-analysis in Chinese and European individuals identifies ten new loci associated with systemic lupus erythematosus (2016) (235)
Impaired clearance of dying cells in systemic lupus erythematosus. (2005) (222)
SLE--a disease of clearance deficiency? (2005) (215)
Leishmania disease development depends on the presence of apoptotic promastigotes in the virulent inoculum (2006) (212)
12/15-lipoxygenase orchestrates the clearance of apoptotic cells and maintains immunologic tolerance (2011) (210)
Adverse events and efficacy of TNF-alpha blockade with infliximab in patients with systemic lupus erythematosus: long-term follow-up of 13 patients. (2009) (185)
Clearance of apoptotic cells in human SLE. (2006) (176)
Role of the guanosine triphosphatase Rac2 in T helper 1 cell differentiation. (2000) (175)
Factors masking HMGB1 in human serum and plasma (2007) (170)
Complement binding is an early feature of necrotic and a rather late event during apoptotic cell death (2001) (165)
Inhibition of Phosphatidylserine Recognition Heightens the Immunogenicity of Irradiated Lymphoma Cells In Vivo (2004) (165)
Activation of tumor-specific T lymphocytes by radio-frequency ablation of the VX2 hepatoma in rabbits. (2003) (162)
Sodium Overload and Water Influx Activate the NALP3 Inflammasome (2010) (157)
Histone-specific Th0 and Th1 clones derived from systemic lupus erythematosus patients induce double-stranded DNA antibody production. (1997) (151)
T Cell Costimulation Molecules CD80/86 Inhibit Osteoclast Differentiation by Inducing the IDO/Tryptophan Pathway (2014) (146)
12/15-Lipoxygenase Counteracts Inflammation and Tissue Damage in Arthritis (2009) (144)
Remnants of secondarily necrotic cells fuel inflammation in systemic lupus erythematosus. (2009) (122)
Proteasome Inhibition with Bortezomib Depletes Plasma Cells and Autoantibodies in Experimental Autoimmune Myasthenia Gravis (2011) (121)
How antirheumatic drugs protect joints from damage in rheumatoid arthritis. (2008) (119)
Impact of Rituximab on Immunoglobulin Concentrations and B Cell Numbers after Cyclophosphamide Treatment in Patients with ANCA-Associated Vasculitides (2012) (117)
Cooperation between C1q and DNase I in the clearance of necrotic cell-derived chromatin. (2004) (117)
Increased bone density and resistance to ovariectomy-induced bone loss in FoxP3-transgenic mice based on impaired osteoclast differentiation. (2010) (103)
Anti-inflammatory effect of low-dose X-irradiation and the involvement of a TGF-β 1 -induced down-regulation of leukocyte/endothelial cell adhesion (2002) (100)
Inhibition of NF-κB Activity and Enhancement of Apoptosis by the Neuropeptide Calcitonin Gene-related Peptide* (2000) (94)
Inefficient clearance of dying cells in patients with SLE: anti-dsDNA autoantibodies, MFG-E8, HMGB-1 and other players (2010) (93)
A Subclass of Ras Proteins That Regulate the Degradation of IκB (2000) (93)
Inefficient clearance of dying cells and autoreactivity. (2006) (92)
Rituximab in the treatment of refractory or relapsing eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome) (2013) (89)
Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time Course (2019) (89)
Involvement of phosphatidylserine, αvβ3, CD14, CD36, and complement C1q in the phagocytosis of primary necrotic lymphocytes by macrophages (2006) (87)
DNA Damage Signaling Instructs Polyploid Macrophage Fate in Granulomas (2016) (83)
Treatment with annexin V increases immunogenicity of apoptotic human T-cells in Balb/c mice (2000) (80)
Apoptosis-induced histone H3 methylation is targeted by autoantibodies in systemic lupus erythematosus (2010) (79)
Viable, apoptotic and necrotic monocytes expose phosphatidylserine: cooperative binding of the ligand Annexin V to dying but not viable cells and implications for PS-dependent clearance (2005) (79)
Pathogenesis of autoimmunity in common variable immunodeficiency (2012) (73)
Apoptosis and systemic lupus erythematosus. (2004) (72)
NF-κB inhibitor targeted to activated endothelium demonstrates a critical role of endothelial NF-κB in immune-mediated diseases (2013) (72)
B cell repopulation kinetics after rituximab treatment in ANCA-associated vasculitides compared to rheumatoid arthritis, and connective tissue diseases: a longitudinal observational study on 120 patients (2017) (70)
Older age, comorbidity, glucocorticoid use and disease activity are risk factors for COVID-19 hospitalisation in patients with inflammatory rheumatic and musculoskeletal diseases (2021) (67)
Helix-loop-helix proteins regulate pre-TCR and TCR signaling through modulation of Rel/NF-kappaB activities. (2002) (66)
After shrinkage apoptotic cells expose internal membrane-derived epitopes on their plasma membranes (2008) (65)
Successful treatment of extensive calcifications and acute pulmonary involvement in dermatomyositis with the Janus-Kinase inhibitor tofacitinib - A report of two cases. (2019) (63)
High frequency of autoantibody‐secreting cells and long‐lived plasma cells within inflamed kidneys of NZB/W F1 lupus mice (2011) (62)
Proteasome inhibition drastically but reversibly impairs murine lymphocyte development (2008) (60)
Lectins detect changes of the glycosylation status of plasma membrane constituents during late apoptosis (2006) (59)
Differential role of the transcription factor NF-kappaB in selection and survival of CD4+ and CD8+ thymocytes. (2008) (59)
Involvement of phosphatidylserine, alphavbeta3, CD14, CD36, and complement C1q in the phagocytosis of primary necrotic lymphocytes by macrophages. (2006) (57)
Dose‐dependent biphasic induction and transcriptional activity of nuclear factor kappa B (NF‐κB) in EA.hy.926 endothelial cells after low‐dose X‐irradiation (2004) (55)
Rituximab as Induction Therapy in Eosinophilic Granulomatosis with Polyangiitis Refractory to Conventional Immunosuppressive Treatment: A 36-Month Follow-Up Analysis. (2017) (54)
High mobility group box 1 in the pathogenesis of inflammatory and autoimmune diseases. (2008) (54)
Siglec-G Regulates B1 Cell Survival and Selection (2010) (54)
Circulating chromogranin A reveals extra‐articular involvement in patients with rheumatoid arthritis and curbs TNF‐α‐elicited endothelial activation (2008) (54)
Oxidation of the alarmin high-mobility group box 1 protein (HMGB1) during apoptosis (2009) (52)
Bone‐ and Cartilage‐Protective Effects of a Monoclonal Antibody Against Colony‐Stimulating Factor 1 Receptor in Experimental Arthritis (2014) (52)
Abatacept modulates CD80 and CD86 expression and memory formation in human B-cells. (2019) (52)
Exposure of anionic phospholipids serves as anti-inflammatory and immunosuppressive signal--implications for antiphospholipid syndrome and systemic lupus erythematosus. (2003) (51)
Bortezomib and sirolimus inhibit the chronic active antibody-mediated rejection in experimental renal transplantation in the rat. (2010) (49)
Toll-like receptor 2 is required for autoantibody production and development of renal disease in pristane-induced lupus. (2013) (49)
The protein tyrosine phosphatase PTP1B is a negative regulator of CD40 and BAFF-R signaling and controls B cell autoimmunity (2014) (47)
Sensitive detection of plasma/serum DNA in patients with systemic lupus erythematosus (2007) (47)
The Induction of TGF-β1 and NF-κB Parallels a Biphasic Time Course of Leukocyte/Endothelial Cell Adhesion Following Low-Dose X-Irradiation (2004) (47)
Vaccination survey in patients with rheumatoid arthritis: a cross-sectional study (2012) (46)
A subclass of Ras proteins that regulate the degradation of IkappaB. (2000) (45)
Defects in the disposal of dying cells lead to autoimmunity (2004) (45)
The expansion of human T-bethighCD21low B cells is T cell dependent (2021) (44)
Early detection of apoptosis by staining of acid‐treated apoptotic cells with FITC‐labeled lectin from Narcissus pseudonarcissus (2003) (43)
The Proteasome Inhibitor Bortezomib Prevents Lupus Nephritis in the NZB/W F1 Mouse Model by Preservation of Glomerular and Tubulointerstitial Architecture (2012) (43)
Do We Need New Treatment That Goes beyond Tumor Necrosis Factor Blockers for Rheumatoid Arthritis? (2005) (42)
Activation of NF-kappaB promotes the transition of large, CD43+ pre-B cells to small, CD43- pre-B cells. (2005) (42)
Discontinuous induction of X-linked inhibitor of apoptosis in EA.hy.926 endothelial cells is linked to NF-κB activation and mediates the anti-inflammatory properties of low-dose ionising-radiation. (2010) (42)
National registry for patients with inflammatory rheumatic diseases (IRD) infected with SARS-CoV-2 in Germany (ReCoVery): a valuable mean to gain rapid and reliable knowledge of the clinical course of SARS-CoV-2 infections in patients with IRD (2020) (41)
Calcium Channel Blocker Verapamil Enhances Reticulum Stress and Death Induced by Proteasome Inhibition in Myeloma Cells (2010) (40)
Secondary Antibody Deficiency in Glucocorticoid Therapy Clearly Differs from Primary Antibody Deficiency (2016) (40)
What triggers anti-dsDNA antibodies? (2004) (40)
Impact of tofacitinib treatment on human B-cells in vitro and in vivo. (2017) (39)
Inhibition of NF-kappaB activity and enhancement of apoptosis by the neuropeptide calcitonin gene-related peptide. (2000) (39)
Disposal of dying cells: a balancing act between infection and autoimmunity. (2003) (38)
Autoantibodies against Modified Histone Peptides in SLE Patients Are Associated with Disease Activity and Lupus Nephritis (2016) (37)
Reconstitution of the peripheral B lymphocyte compartment in patients with ANCA-associated vasculitides treated with rituximab for relapsing or refractory disease (2014) (36)
Hydrostatic pressure induced death of mammalian cells engages pathways related to apoptosis or necrosis. (2004) (35)
UV irradiation inhibits ABC transporters via generation of ADP-ribose by concerted action of poly(ADP-ribose) polymerase-1 and glycohydrolase (2004) (34)
Calcium channel blocker verapamil enhances endoplasmic reticulum stress and cell death induced by proteasome inhibition in myeloma cells. (2010) (34)
CD20 as a gatekeeper of the resting state of human B cells (2020) (33)
Polymorphisms in the Hsp70 gene locus are genetically associated with systemic lupus erythematosus (2010) (33)
Removal of dying cells and systemic lupus erythematosus (2005) (33)
The induction of TGF-beta(1) and NF-kappaB parallels a biphasic time course of leukocyte/endothelial cell adhesion following low-dose X-irradiation. (2004) (32)
Loading of nuclear autoantigens prototypically recognized by systemic lupus erythematosus sera into late apoptotic vesicles requires intact microtubules and myosin light chain kinase activity (2015) (32)
IgG autoantibodies bound to surfaces of necrotic cells and complement C4 comprise the phagocytosis promoting activity for necrotic cells of systemic lupus erythaematosus sera (2007) (31)
Microparticles Shed from Different Antigen‐Presenting Cells Display an Individual Pattern of Surface Molecules and a Distinct Potential of Allogeneic T‐Cell Activation (2005) (30)
HMGB1 and RAGE in skeletal muscle inflammation: Implications for protein accumulation in inclusion body myositis (2015) (29)
Characteristics associated with poor COVID-19 outcomes in individuals with systemic lupus erythematosus: data from the COVID-19 Global Rheumatology Alliance (2022) (29)
Impaired clearance of apoptotic cells in systemic lupus erythematosus: Challenge of T and B cell tolerance (2003) (29)
Vegan diet reduces neutrophils, monocytes and platelets related to branched-chain amino acids - A randomized, controlled trial. (2020) (28)
Detection of restricted junctional diversity of peripheral T cells in SLE patients by spectratyping (1997) (28)
Composition of clogging material in pancreatic endoprostheses. (2005) (28)
Serum Levels of HMGB1 in Postmenopausal Patients with Rheumatoid Arthritis: Associations with Proinflammatory Cytokines, Acute-phase Reactants, and Clinical Disease Characteristics (2011) (28)
Whipple’s disease mimicking rheumatoid arthritis can cause misdiagnosis and treatment failure (2017) (27)
Mucin production determines sensitivity to bortezomib and gemcitabine in pancreatic cancer cells. (2012) (27)
Methylation-dependent activation of CDX1 through NF-κB: a link from inflammation to intestinal metaplasia in the human stomach. (2012) (27)
Arterial and venular endothelial cell costimulation of cytokine secretion by human T cell clones (1998) (26)
Cell-Intrinsic NF-κB Activation Is Critical for the Development of Natural Regulatory T Cells in Mice (2011) (26)
Soluble human CD83 ameliorates lupus in NZB/W F1 mice. (2013) (26)
After shrinkage apoptotic cells expose internal membrane-derived epitopes on their plasma membranes (2007) (26)
FcgammaRIIa genotype is associated with acute coronary syndromes as first manifestation of coronary artery disease. (2009) (25)
Cell-Type Targeted NF-kappaB Inhibition for the Treatment of Inflammatory Diseases (2020) (25)
Agonistic Autoantibodies to the β2-Adrenergic Receptor Involved in the Pathogenesis of Open-Angle Glaucoma (2018) (25)
Interaction of histones with phospholipids—implications for the exposure of histones on apoptotic cells (2007) (24)
Loss of GM1 surface expression precedes annexin V‐phycoerythrin binding of neutrophils undergoing spontaneous apoptosis during in vitro aging (2004) (24)
Activator protein 1 shows a biphasic induction and transcriptional activity after low dose X-irradiation in EA.hy.926 endothelial cells (2009) (23)
Triggering of NF‐κB in cytokine‐matured human DCs generates superior DCs for T‐cell priming in cancer immunotherapy (2014) (23)
Outcomes of COVID-19 in patients with primary systemic vasculitis or polymyalgia rheumatica from the COVID-19 Global Rheumatology Alliance physician registry: a retrospective cohort study (2021) (23)
Ex vivo– and in vivo–induced dead tumor cells as modulators of antitumor responses (2010) (22)
Apoptotic cells selectively suppress the Th1 cytokine interferon γ in stimulated human peripheral blood mononuclear cells and shift the Th1/Th2 balance towards Th2 (2007) (22)
Naive- and Memory-like CD21low B Cell Subsets Share Core Phenotypic and Signaling Characteristics in Systemic Autoimmune Disorders (2020) (21)
Amelioration of type II collagen induced arthritis in rats by treatment with sodium diethyldithiocarbamate. (1999) (20)
CD4 positive peripheral T cells from patients with systemic lupus erythematosus (SLE) are clonally expanded (2001) (20)
Low Dietary Fiber Intake Links Development of Obesity and Lupus Pathogenesis (2021) (19)
The Antigen Presenting Potential of CD21low B Cells (2020) (19)
B cell homeostasis is disturbed by immunosuppressive therapies in patients with ANCA-associated vasculitides (2013) (18)
High Levels of SOX5 Decrease Proliferative Capacity of Human B Cells, but Permit Plasmablast Differentiation (2014) (18)
Proteasome inhibition aggravates tumor necrosis factor-mediated bone resorption in a mouse model of inflammatory arthritis. (2011) (18)
Modulation of granulocyte-endothelium interactions by antileukoproteinase: inhibition of anti-type II collagen antibody-induced leukocyte attachment to the synovial endothelium (2006) (17)
Renal uptake of the antiapoptotic protein survivin is mediated by megalin at the apical membrane of the proximal tubule. (2013) (17)
Soluble CD90 as a potential marker of pulmonary involvement in systemic sclerosis (2013) (17)
Abatacept used in combination with non-methotrexate disease-modifying antirheumatic drugs: a descriptive analysis of data from interventional trials and the real-world setting (2018) (16)
Patterns of fatigue and association with disease activity and clinical manifestations in systemic lupus erythematosus. (2020) (16)
TNFi is associated with positive outcome, but JAKi and rituximab are associated with negative outcome of SARS-CoV-2 infection in patients with RMD (2021) (15)
The Early Marginal Zone B Cell-Initiated T-Independent Type 2 Response Resists the Proteasome Inhibitor Bortezomib (2010) (15)
Preclinical evaluation of NF-κB-triggered dendritic cells expressing the viral oncogenic driver of Merkel cell carcinoma for therapeutic vaccination (2017) (15)
A new regulatory mechanism of NF-kappaB activation by I-kappaBbeta in cancer cells. (2008) (15)
A reverse translational study on the effect of rituximab, rituximab plus belimumab, or bortezomib on the humoral autoimmune response in SLE (2020) (14)
The role of high-mobility group box 1 protein in the pathogenesis of autoimmune diseases (2008) (13)
The CFSE Distribution Assay is a Powerful Technique for the Analysis of Radiation–Induced Cell Death and Survival on a Single–Cell Level (2005) (13)
[IL-1-blockade with Anakinra during pregnancy : Retrospective analysis of efficacy and safety in female patients with familial Mediterranean fever]. (2018) (12)
Coagulation activation and fluid retention associated with the use of black cohosh: a case study (2010) (12)
COVID-19 in a Severely Immunosuppressed Patient With Life-Threatening Eosinophilic Granulomatosis With Polyangiitis (2020) (12)
Bronchoalveolar lavage cytology resembles sarcoidosis in a subgroup of granulomatous CVID (2014) (12)
NF-κB activation triggers NK-cell stimulation by monocyte-derived dendritic cells (2019) (12)
Staphylococcus aureus bacteremia in patients with rheumatoid arthritis - Data from the prospective INSTINCT cohort. (2017) (12)
Long-Term Partial Remission of AutoImmune Thrombocytopenia in a Patient Treated with the Anti-Tumor Necrosis Factor-Alpha Antibody Infliximab for Refractory Fistulizing Crohn’s Disease (2008) (12)
Plasmacytoid dendritic cell activation is dependent on coordinated expression of distinct amino acid transporters. (2021) (12)
CCL18 — Potential Biomarker of Fibroinflammatory Activity in Chronic Periaortitis (2012) (12)
CMTM6-Deficient Monocytes in ANCA-Associated Vasculitis Fail to Present the Immune Checkpoint PD-L1 (2021) (11)
Dual Role of Interleukin-10 in Murine NZB/W F1 Lupus (2021) (11)
Serological lymphocytic activity and patient-reported outcomes in Sjögren’s syndrome (2018) (11)
Patients with unstable angina pectoris show an increased frequency of the Fc gamma RIIa R131 allele (2012) (11)
DNA Damage Signaling Instructs Polyploid Macrophage Fate in Granulomas (2018) (10)
Signals, receptors, and cytokines involved in the immunomodulatory and anti-inflammatory properties of apoptotic cells (2005) (9)
A randomised, open-label trial to assess the optimal treatment strategy in early diffuse cutaneous systemic sclerosis: the UPSIDE study protocol (2021) (9)
Inflammatory stays inflammatory: a subgroup of systemic sclerosis characterized by high morbidity and inflammatory resistance to cyclophosphamide (2019) (9)
Hypothesis: human serum-borne albumin bound lipids promote cellular survival after apoptosis induction by a variety of stimuli (2008) (9)
Sneaking-ligand fusion proteins attenuate serum transfer arthritis by endothelium-targeted NF-κB inhibition. (2015) (8)
Systemic lupus erythematosus and neutropaenia: a hallmark of haematological manifestations (2020) (8)
Peripheral Blood Stem Cells of Patients with Systemic Lupus Erythematosus Show Altered Differentiation into Macrophages (2010) (8)
Therapeutic inhibition of proteasomes in systemic lupus erythematosus (2011) (7)
Circulating multimeric immune complexes drive immunopathology in COVID-19 (2021) (7)
Association of High Mobility Group Box Chromosomal Protein 1 and Receptor for Advanced Glycation End Products Serum Concentrations With Extraglandular Involvement and Disease Activity in Sjögren's Syndrome (2018) (7)
A multicenter blinded preclinical randomized controlled trial on Jak1/2 inhibition in MRL/MpJ-Faslpr mice with proliferative lupus nephritis predicts low effect size. (2021) (7)
Clinical spectrum time course in non-Asian patients positive for anti-MDA5 antibodies. (2022) (7)
Do low vitamin D levels cause problems of waste removal in patients with SLE? (2012) (7)
The role of a defective clearance in the pathogenesis of systemic lupus erythematosus (2004) (7)
Apoptosis of the Teratocarcinoma Cell Line Tera‐1 Leads to the Cleavage of HERV‐K10gag Proteins by Caspases and/or Granzyme B (2002) (7)
Do patients with rheumatoid arthritis show a different course of COVID-19 compared to patients with spondyloarthritis? (2021) (7)
Elevated serum osteopontin levels in idiopathic retroperitoneal fibrosis. (2012) (7)
Role of NF-kappa B in T-lymphocyte development. (1999) (7)
IgG4-related disease in autoimmune lymphoproliferative syndrome. (2017) (6)
Blastic CD56+ natural killer-cell lymphoma with primary cutaneous manifestation. (2003) (6)
Cell Survival Failure in Effector T Cells From Patients With Systemic Lupus Erythematosus Following Insufficient Up‐Regulation of Cold‐Shock Y‐Box Binding Protein 1 (2020) (5)
Inhibition of NF- k B Activity and Enhancement of Apoptosis by the Neuropeptide Calcitonin Gene-related Peptide* (2000) (5)
[Updated recommendations of the German Society for Rheumatology for the care of patients with inflammatory rheumatic diseases in the context of the SARS-CoV‑2/COVID‑19 pandemic, including recommendations for COVID‑19 vaccination]. (2021) (5)
Non permissive bone marrow environment impairs early B-cell development in common variable immunodeficiency. (2020) (5)
Optimized isolation of renal plasma cells for flow cytometric analysis. (2019) (5)
[Plasma cells]. (2015) (5)
The "sneaking-ligand" approach: cell-type specific inhibition of the classical NF-κB pathway. (2015) (5)
The low-throughput protein A adsorber: an immune modulatory device. Hypothesis for the mechanism of action in the treatment of rheumatoid arthritis (2005) (5)
Retinal Vessel Diameters and Physical Activity in Patients With Mild to Moderate Rheumatic Disease Without Cardiovascular Comorbidities (2018) (5)
[Depletion of plasma cells - a novel strategy in the therapy of systemic lupus erythematosus in mice and man]. (2009) (5)
Selective silencing of autoreactive B lymphocytes-Following the Nature's way. (2010) (5)
Swimming against the stream: the fishbowl discussion method as an interactive tool for medical conferences: experiences from the 11th European Lupus Meeting (2018) (5)
Neuraminidase Inhibitor Zanamivir Ameliorates Collagen-Induced Arthritis (2021) (4)
Possible misclassification of cardiovascular risk by SCORE in antisynthetase syndrome: results of the pilot multicenter study RI.CAR.D.A. (2020) (4)
A Barcoded Flow Cytometric Assay to Explore the Antibody Responses Against SARS-CoV-2 Spike and Its Variants (2021) (4)
Detection and functional resolution of soluble immune complexes by an FcγR reporter cell panel (2021) (4)
[The role of incomplete clearance of apoptotic cells in the etiology and pathogenesis of SLE]. (2010) (4)
Low-Salt Diet Attenuates B-Cell- and Myeloid-Cell-Driven Experimental Arthritides by Affecting Innate as Well as Adaptive Immune Mechanisms (2021) (3)
Targeted silencing of DNA‐specific B cells combined with partial plasma cell depletion displays additive effects on delaying disease onset in lupus‐prone mice (2013) (3)
Updated recommendations of the German Society for Rheumatology for the care of patients with inflammatory rheumatic diseases in the context of the SARS-CoV-2/COVID-19 pandemic, including recommendations for COVID-19 vaccination (2021) (3)
Failure of upregulation of the cold shock Y-box protein-1 in effector T-cells of systemic lupus erythematosus patients averts cell survival. (2020) (3)
A survey to evaluate knowledge, perceptions and attitudes toward COVID-19 vaccinations among rheumatologists in Germany (2021) (3)
Circulating mitochondrial DNA copy numbers represent a sensitive marker for diagnosis and monitoring of disease activity in systemic lupus erythematosus (2021) (3)
Social class, social mobility and status differences in marriage: Relevant for child psychiatry? (2004) (3)
Polymorphisms in the Hsp 70 gene locus are genetically associated with systemic lupus erythematosus (2010) (3)
Relevance of Receptor for Advanced Glycation end Products (RAGE) in Murine Antibody-Mediated Autoimmune Diseases (2019) (3)
[Off-label biologic therapy of ANCA-associated and non-ANCA-associated small-vessel vasculitis : Efficacy and safety analysis of a national registry (GRAID2)]. (2018) (3)
Small DNA fragments isolated from human T-cell clones are enriched in sequences involved in DNA bending. (1996) (3)
CO0004 OLDER AGE, CARDIOVASCULAR COMORBIDITY AND GLUCOCORTICOSTEROIDS ARE RISK FACTORS FOR COVID-19 HOSPITALISATION IN PATIENTS WITH INFLAMMATORY RHEUMATIC DISEASES: FIRST RESULTS OF THE GERMAN COVID-19-IRD REGISTRY (2020) (3)
Case Report: Effective and Safe Treatment With Certolizumab Pegol in Pregnant Patients With Cogan’s Syndrome: A Report of Three Pregnancies in Two Patients (2021) (3)
Factors associated with severe COVID-19 in people with idiopathic inflammatory myopathy: results from the COVID-19 Global Rheumatology Alliance physician-reported registry (2022) (3)
[Vaccinations in rheumatology]. (2010) (3)
The MRZ-Reaction and Specific Autoantibody Detection for Differentiation of ANA-Positive Multiple Sclerosis From Rheumatic Diseases With Cerebral Involvement (2019) (3)
Absence of Anti-Glomerular Basement Membrane Antibodies in 200 Patients With Systemic Lupus Erythematosus With or Without Lupus Nephritis: Results of the GOODLUPUS Study (2020) (2)
CVID-Associated B Cell Activating Factor Receptor Variants Change Receptor Oligomerization, Ligand Binding, and Signaling Responses (2021) (2)
Circulating multimeric immune complexes contribute to immunopathology in COVID-19 (2022) (2)
Clinical images: Multilocular tenosynovitis as a manifestation of sarcoidosis. (2012) (2)
[Prospective multicenter observational study of early rheumatoid arthritis--prognostic factors and predictors of disease course]. (2000) (2)
[Safety and efficacy of off-label use of biologic therapies in patients with inflammatory rheumatic diseases refractory to standard of care therapy : Data from a nationwide German registry (GRAID2)]. (2018) (2)
Immune complexes as culprits of immunopathology in severe COVID-19 (2022) (2)
Unmet need in rheumatology: reports from the Advances in Targeted Therapies meeting, 2022 (2023) (2)
A non-peptide AT2 receptor agonist attenuates clinical and histological signs in murine collagen-induced arthritis (2012) (2)
A marriage with sarcoidosis (2013) (2)
Immune complex solubility and size govern Fc-gamma receptor responses: A scalable cell-based reporter system (2020) (2)
Interferon Lambda Regulates Cellular and Humoral Immunity in Pristane-Induced Lupus (2021) (2)
Sleep apnea in Sjögren’s syndrome potentially influences the EULAR Sjögren’s syndrome patient reported index (2018) (2)
[Lupus erythematosus - Update 2016]. (2016) (2)
Abatacept retention and clinical outcomes in rheumatoid arthritis: real-world data from the German cohort of the ACTION study and a comparison with other participating countries (2019) (2)
Angiotensin AT2 Receptor Stimulation Alleviates Collagen-Induced Arthritis by Upregulation of Regulatory T Cell Numbers (2022) (2)
Spuriously low IgG levels in lupus-associated mixed cryoglobulinaemia type II complicated by iatrogenic immunoglobulin-induced immune complex vasculitis. (2012) (2)
High antibody levels and reduced cellular response in children up to one year after SARS-CoV-2 infection (2022) (2)
Anti‐Inflammatory and Immunoregulatory Effects of Apoptotic Cells (2004) (2)
The sneaking ligand approach for cell type-specific modulation of intracellular signalling pathways. (2017) (2)
[Reality of inpatient vasoactive treatment with prostacyclin derivatives in patients with acral circulation disorders due to systemic sclerosis in Germany]. (2020) (2)
P55 Influence of dietary fibre and short-chain fatty acids on the pathogenesis of systemic lupus erythematosus (2020) (2)
BAFFR activates PI3K/AKT signaling in human naive but not in switched memory B cells through direct interactions with B cell antigen receptors. (2022) (2)
Involvement of toll-like receptor 2 in pristane-induced lupus (2011) (2)
12/15-lipoxygenase orchestrates the clearance of apoptotic cells and maintains immunological tolerance (2011) (1)
Mucin production determines sensitivity to bortezomib and gemcitabine in pancreatic cancer cells (2010) (1)
A Tissue-specific NF-κB inhibitor ameliorates inflammatory joint diseases (2010) (1)
Introduction: B cell-mediated autoimmune diseases (2014) (1)
Novel treatment strategies for antibody-mediated diseases: targeting long-lived plasma cells (2008) (1)
Abstract 406: Direct Angiotensin AT2-Receptor Stimulation Modifies T-Cell Differentiation (2014) (1)
Methotrexate plus ustekinumab versus ustekinumab monotherapy in patients with active psoriatic arthritis (MUST): a randomised, multicentre, placebo-controlled, phase 3b, non-inferiority trial (2023) (1)
HMGB1 containing nucleosomes from apoptotic cells induce inflammation and immune activation via TLR2 – implications for the etiopathogenesis of systemic lupus erythematosus (2010) (1)
Rheumatoid factor IgM autoantibodies control IgG homeostasis (2022) (1)
Correspondence to ‘Risk factors for hospital admissions related to COVID-19 in patients with autoimmune inflammatory rheumatic diseases’ (2020) (1)
SAT0177 12/15-lipoxygenase orchestrates the clearance of apoptotic cells and maintains immunologic tolerance (2013) (1)
POS1261 DISEASE ACTIVITY AND PAIN LEVELS ARE NOT INFLUENCED BY THE CURRENT COVID19 PANDEMIC IN PATIENTS WITH RHEUMATIC DISEASES IN GERMANY – DATA FROM THE GERMAN COVID-19 PATIENT SURVEY (2021) (1)
AB0593 Predictors of fatigue and severe fatigue in a large multicenter international cohort of patients with systemic lupus erythematosus: the fatilup study (2018) (1)
OP0283 DOES TNF-INHIBITION DECREASE THE RISK OF SEVERE COVID-19 IN RMD-PATIENTS? (2021) (1)
Exosomes Secreted By Multiple Myeloma Cell Lines (MMCLs) and Bone Marrow Stromal Cells (BMSCs) Reciprocally Modulate Cell Adhesion and Impact on MM Cell Migration and Bortezomib-Induced Apoptosis (2014) (1)
[Television watching, reading habits and psychiatric disorders in 8-year-old children]. (1983) (1)
Dose-dependent biphasic expression of nuclear factor KappaB (NF-κB) in endothelial cells by low-dose ionizing radiation (2001) (1)
Lupus erythematodes – Update 2016 (2016) (1)
Detection and functional resolution of soluble multimeric immune complexes (2021) (1)
Apoptosis and Necrosis of Mammalian Cells after High Pressure Treatment — Prospects for a Tumor Vaccine (2003) (1)
New bortezomib-based combination therapy for elimination of myeloma cells (2009) (1)
Autoantibody secreting cells and long-lived plasma cells are enriched within inflamed kidneys of NZB/NZW F1 lupus mice and sensitive to bortezomib treatment (2011) (1)
The Low Throughput Protein A Adsorber: An Immune Modulatory Device for the Treatment of Rheumatoid Arthritis (2007) (1)
7.3 Akute Pyelonephritis (2013) (0)
5.3 Reizdarmsyndrom (RDS) (2013) (0)
THU0029 Ctla-4-ig treatment induces modulation of b-cell function and differentiation (2018) (0)
2.9 Invasive Methoden (2013) (0)
AB0033 CHARACTERIZATION OF THE PERIPHERAL B CELL COMPARTMENT IN PATIENTS WITH EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (2020) (0)
3.6 Zyanose (2013) (0)
Medicine, particularly for modulating the immune response den fighting viruses, tumors, bacteria and parasites. (1996) (0)
Zellstress-assoziierte Expression von High Mobility Group Box (HMGB)-1 und dessen Receptor for Advanced Glycation Endproducts (RAGE) im Skelettmuskel der sporadischen Einschlusskörperchenmyositis (sIBM) (2008) (0)
THU0379 DEPRESSIVE SYMPTOMS AND FUNCTIONAL IMPAIRMENT ARE FREQUENT AND AFFECT QUALITY OF LIFE IN ANKYLOSING SPONDYLITIS AND PSORIATIC ARTHRITIS: A QUESTIONNAIRE-BASED ASSESSMENT OF 300 PATIENTS COMPARED WITH 150 PATIENTS WITH PSORIASIS AND 150 PATIENTS WITH MECHANICAL BACK PAIN (2019) (0)
manipulated dendritic cells in its path signal transmission NFkB (2011) (0)
FRI0311 The effect of b cell targeted therapies on autoantibodies and excessive neutrophil extracellular trap formation in systemic lupus erythematosus patients (2018) (0)
CD56+-NK-Zell-Lymphome (2003) (0)
Kutane CD 56 positive NK-Zell-Lymphome (2003) (0)
OP0218 CENTRAL NERVOUS SYSTEM PAIN RESPONSE AND COMPONENTS OF DISEASE ACTIVITY IN RA PATIENTS AFTER TREATMENT WITH CERTOLIZUMAB OR PLACEBO: A POST-HOC ANALYSIS FROM THE PRECEPRA TRIAL (2020) (0)
Introduction: B cell-mediated autoimmune diseases (2014) (0)
07 Plasma-cell directed therapies (2020) (0)
2.1 Zyanose (2013) (0)
4.5 Morbus Whipple (Lipodystrophia intestinalis) (2013) (0)
Promotor Methylation in Gastric Cancer – A Functional Trigger of Intestinal Differentiation Under Special Consideration of CDX1 Expression and NfκB Signalling (2011) (0)
B cell depletion by Rituximab severely reduces immunoglobulin levels in patients with ANCA-associated vasculitis previously treated with cyclophosphamide (2011) (0)
5.1 Akute Tracheobronchitis (2013) (0)
Characteristics and outcomes of SARS-CoV-2 breakthrough infections among double-vaccinated and triple-vaccinated patients with inflammatory rheumatic diseases (2023) (0)
THU0341 FLT3 ligand concentrations are elevated in anca-associated vasculitides (AAV) and are influenced by immunosuppressive therapy (2017) (0)
11.7 Meningitis Meningitis (2015) (0)
5.2 Leitsymptom: Splenomegalie (2013) (0)
3.1 Transplantation (2013) (0)
13.3 Schock (2013) (0)
New aspects of the etiopathogenesis of systemic lupus erythematosus (2003) (0)
Immune complex solubility and size govern individual Fc-gamma receptor 1 responses : Novel biomarkers for autoimmune diseases 2 (2021) (0)
SAT0050 PREDICTION OF RESPONSE TO CERTOLIZUMAB PEGOL TREATMENT BY FUNCTIONAL MRI OF THE BRAIN: AN INTERNATIONAL, MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL (PRECEPRA) (2020) (0)
AB0388 IMPROVEMENT OF PATIENT-REPORTED OUTCOMES IN PATIENTS WITH PRIMARY SJÖGREN’S SYNDROME UNDERGOING CPAP-TREATMENT (2020) (0)
4.16 Listeriose (2013) (0)
9.1 Definition (2013) (0)
5.3 Lungenemphysem (2013) (0)
4.15 Leptospirosen (2013) (0)
OP0117 LONGITUDINAL CHANGE IN THE CENTRAL NERVOUS SYSTEM PAIN RESPONSE AFTER TREATMENT WITH CERTOLIZUMAB OR PLACEBO. A POST-HOC ANALYSIS FROM THE PRECEPRA TRIAL (2020) (0)
5.1 Definition (2007) (0)
[German registry www.Covid19-Rheuma.de : Status report after 1 year of the pandemic]. (2021) (0)
JAK inhibitors differentially modulate B cell activation, maturation and function: A comparative analysis of five JAK inhibitors in an in-vitro B cell differentiation model and in patients with rheumatoid arthritis (2023) (0)
2.5 Hiatushernie (2013) (0)
Fatigue is independently associated with disease activity assessed using the Physician Global Assessment but not the SLEDAI in patients with systemic lupus erythematosus (2022) (0)
5.4 Enterokolitiden (2013) (0)
Das Sjögren-Syndrom (2017) (0)
AB0682 FUNCTIONAL IMPAIRMENT IN PATIENTS WITH AXIAL SPONDYLOARTHROPATHY IN A GERMAN COHORT: WORSE OUTCOMES AND WORSE QUALITY OF LIFE FOR FEMALE PATIENTS (2020) (0)
2.2 Dyspnoe (2013) (0)
FRI0339 B cell repopulation kinetics after rituximab treatment in anca-associated vasculitides compared to rheumatoid arthritis, and connective tissue diseases: a longitudinal observational study on 120 patients (2017) (0)
2.2 Spondyloarthritiden (SpA) (2013) (0)
HMGB1 and RAGE in skeletal muscle inflammation: Implications for protein accumulation in inclusion body myositis (IBM) (2014) (0)
[Macrocytic anemia and polychondritis: VEXAS syndrome]. (2023) (0)
4.4 Glutensensitive Enteropathie (2013) (0)
Chinese-European SLE GWAS meta-analysis findings include ten 1 new loci and a genetic basis for increased non-European 2 prevalence 3 (2016) (0)
10.5 Kyphoskoliose (2013) (0)
23.3 Kollagenosen (2011) (0)
Innate vs acquired immunity (2013) (0)
27.5 Hypothyreose (2011) (0)
Lymphoid stromal cells - potential implications for the pathogenesis of CVID (2023) (0)
13.1 Akutes Abdomen (2007) (0)
The role of cholesterol in TCR signalling in autoimmune diseases (2021) (0)
5.3 Pathogenese (2013) (0)
Respiratory tract infections and risk factors for infection in a cohort of 330 patients with axial spondyloarthritis or psoriatic arthritis (2022) (0)
Immundefektsyndrome (2013) (0)
4.6 Brucellosen (2013) (0)
THU0321 Alterations in the peripheral b cell compartment in patients with eosinophilic granulomatosis with polyangiitis (churg-strauss syndrome) (2017) (0)
FRI0502 SEASONAL CLUSTERING OF ACUTE SARCOIDOSIS IN GERMANY AND ASSOCIATIONS WITH AIR POLLUTION (2020) (0)
Subject Index Vol. 78, 2008 (2009) (0)
Favourable outcome of acute hepatitis E infection in patients with ANCA-associated vasculitis (2022) (0)
9.4 Pathogenese (2013) (0)
1.3 Leitsymptome (2013) (0)
P134 A preclinical double-blinded, randomized, controlled, multicenter trial (pRCT) on Jak1/Jak2 inhibition in lupus nephritis (2020) (0)
AB0757 Persistent crp elevation is associated with high morbidity in systemic sclerosis (2018) (0)
IMMUNOSUPPRESSIVE TREATMENT FOR AUTOIMMUNITY, LYMPHOPROLIFERATION AND GRANULOMATOUS COMPLICATIONS IN PATIENTS WITH CVID (2012) (0)
7.2 Akute Appendizitis (2013) (0)
4.3 Hyperventilation (2013) (0)
11.2 Aortenstenose (2013) (0)
Contents Vol. 78, 2008 (2009) (0)
34346 Pooled safety analysis of respiratory tract infections, including COVID-19, in psoriasis patients treated with secukinumab (2022) (0)
11.9 Pulmonalstenose (2013) (0)
4.4 Bartonellose (2013) (0)
THU0053 CONTRIBUTION OF DEFECTIVE NON-APOPTOTIC FAS SIGNALING TO IMMUNE DYSREGULATION IN AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME (ALPS) (2020) (0)
11.2 Nierentransplantation (NTX) (2013) (0)
Analysis of Hand Joint Space Morphology in Women and Men with Hereditary Hemochromatosis (2023) (0)
THU0105 Prediction of response to CERTOLIZUMAB-PEGOL in rheumatoid arthritis (PRECEPRA) by functional MRI of the brain – an interim analysis of an ongoing investigator initiated phase III trial (2017) (0)
AB0701 ANTIBODY RAPID TEST POSITIVE HEALTH CARE WORKERS AT A GERMAN UNIVERSITY HOSPITAL: FIRST WAVE CHARACTERISTICS (2021) (0)
6.2 Aspergillose (2013) (0)
lupus erythematosus clinical manifestations of refractory systemic depletes plasma cells and ameliorates The proteasome inhibitior bortezomib and (2015) (0)
4.9 Cholera (2013) (0)
Experimental pathology - 1 (2009) (0)
Role of apoptosis failure in etiopathogenesis of systemic lupus erythematosus and murine lupus (2008) (0)
4.3 Myeloproliferative Neoplasien (MPN) (2013) (0)
[Visual evoked potentials in 8-year-old children. Normal values and applications in pediatric neurology]. (1984) (0)
A method for immunomodulation (1995) (0)
9.3 Transplantation Transplantation Organtransplantation (2015) (0)
11.5 Mitralstenose (2013) (0)
2.5 Ödeme (2013) (0)
1.1 Definition (2013) (0)
10.5 Arthritiden Arthritiden (2015) (0)
4.1 Definition (2013) (0)
4.3 Leitsymptom (2013) (0)
1.11 Leberzirrhose (2013) (0)
4.1 Leitsymptome (2015) (0)
10.2 Leitsymptome (2015) (0)
Arthritis Inflammation and Tissue Damage in 12/15-Lipoxygenase Counteracts (2009) (0)
2.4 Cholestase (2013) (0)
7.10 Kardiopulmonale Reanimation (2013) (0)
1.5 Geriatrische Rehabilitation (2013) (0)
Inflammatory arthritis in systemic sclerosis is associated with elevated C-reactive protein and requires musculoskeletal ultrasound for reliable detection (2023) (0)
4.8 Adrenogenitales Syndrom (AGS) (2013) (0)
5.6 Transplantation Transplantation (2015) (0)
[Principles of the diagnostics of inborn errors of immunity]. (2023) (0)
7.3 Ileus (2013) (0)
6.2 Transfusionstherapie (2013) (0)
Correlation of mucin production with sensitivity to bortezomib and gemcitabine in pancreatic cancer cells. (2010) (0)
6.2 Phlebothrombose (2013) (0)
9.1 Pneumothorax (2013) (0)
FO055THE EFFECT OF B CELL TARGETED THERAPIES ON AUTOANTIBODIES AND EXCESSIVE NEUTROPHIL EXTRACELLULAR TRAP FORMATION IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS (2018) (0)
3.3 Lymphadenopathie (2013) (0)
FcγR responses to soluble immune complexes of varying size: A scalable cell-based reporter system (2020) (0)
Impact of dietary vitamin D on immunoregulation and disease pathology in lupus-prone NZB/W F1 mice (2022) (0)
Acute Sarcoidosis Clusters in Cold Season and Is Associated with Ambient Air Pollution: A Retrospective Clinical-Meteorological Study. (2021) (0)
Editorial: The Role of Nuclear Molecules in the Pathogenesis of Autoimmune Disease (2021) (0)
7.2 Akute interstitielle Nephritis (AIN) (2013) (0)
THU0103 Therapeutical targeting of antigen-induced arthritis with liposomal secretory leukocyte protease inhibitor (antileukoproteinase) (2001) (0)
Symposium: HMGB1 in Inflammation and Innate Immunity (2011) (0)
SAT0348 CLINICAL SPECTRUM TIME COURSE OF ANTISYNTHETASE SYNDROME PATIENTS POSITIVE FOR ANTICENTROMERE ANTIBODIES (2020) (0)
2.7 Obstipation (2013) (0)
THU0030 DISTINCT EFFECTS OF FIVE JAK INHIBITORS IN THE MODULATION OF HUMAN B CELL ACTIVATION (2020) (0)
6.3 Thrombophlebitis (2013) (0)
Activation of NF-jB promotes the transition of large, CD43 pre-B cells to small, CD43 pre-B cells (2005) (0)
5.6 Prognose (2013) (0)
Secondary Antibody Deficiency in Glucocorticoid Therapy Clearly Differs from Primary Antibody Deficiency (2016) (0)
Proteasome Inhibitor Bortezomib T-Independent Type 2 Response Resists the The Early Marginal Zone B Cell-Initiated (2010) (0)
THU0366 SYSTEMATIC CORONARY RISK EVALUATION (SCORE) MISCLASSIFIES CARDIOVASCULAR RISK IN ANTISYNTHETASE SYNDROME: RESULTS OF THE PILOT MULTICENTRIC STUDY RI.CAR.D.A. (2020) (0)
11.2 Leitsymptome (2015) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Reinhard Edmund Voll?

Reinhard Edmund Voll is affiliated with the following schools:

Yale University
University of Erlangen–Nuremberg
University of Freiburg